Literature DB >> 9098016

Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells.

F Marra1, A Gentilini, M Pinzani, G G Choudhury, M Parola, H Herbst, M U Dianzani, G Laffi, H E Abboud, P Gentilini.   

Abstract

BACKGROUND & AIMS: Platelet-derived growth factor (PDGF) is the most potent mitogen for hepatic stellate cells (HSCs) in vitro. The aim of this study was to investigate the role of phosphatidylinositol 3-kinase (PI 3-K) activation in mediating the biological effects of PDGF on cultured HSCs and its involvement in vivo.
METHODS: HSCs were isolated from normal human livers. PI 3-K was assayed on phosphotyrosine or PDGF-receptor immunoprecipitates by in vitro kinase assay.
RESULTS: Incubation of HSCs with PDGF caused a time-dependent increase in PI 3-K activity. Immunoprecipitation of PDGF-alpha and -beta receptors showed that both subunits associate with active PI 3-K in PDGF-stimulated HSCs. Wortmannin, a specific PI 3-K inhibitor, dose-dependently blocked PI 3-K activity induced by PDGF and inhibited DNA synthesis. PDGF (homodimer)-BB also stimulated HSC chemotaxis, which was inhibited by pretreatment with wortmannin. To explore the potential role of PI 3-K in vivo, liver homogenates from rats treated with CCl4 and from control rats were immunoprecipitated with anti-PDGF-beta-receptor antibodies. Liver injury was associated with increased PDGF-beta-receptor autophosphorylation, and greater PI 3-K activity associated with the receptor itself.
CONCLUSIONS: This study shows that in cultured HSCs, PI 3-K activation is necessary for both mitogenesis and chemotaxis induced by PDGF and that this pathway is up-regulated during liver injury in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9098016     DOI: 10.1016/s0016-5085(97)70144-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  44 in total

1.  Platelet-derived growth factor is a principal inductive factormodulating mannose 6-phosphate/insulin-like growth factor-II receptorgene expression via a distal E-box in activated hepatic stellate cells.

Authors:  J A Weiner; A Chen; B H Davis
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

2.  Platelet-derived growth factor gene delivery stimulates ex vivo gingival repair.

Authors:  Orasa Anusaksathien; Sarah A Webb; Qi-Ming Jin; William V Giannobile
Journal:  Tissue Eng       Date:  2003-08

3.  Withagulatin A inhibits hepatic stellate cell viability and procollagen I production through Akt and Smad signaling pathways.

Authors:  Qiong Liu; Jing Chen; Xu Wang; Liang Yu; Li-hong Hu; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2010-07-19       Impact factor: 6.150

4.  Hypoxia-inducible factor activation in myeloid cells contributes to the development of liver fibrosis in cholestatic mice.

Authors:  Bryan L Copple; Sophia Kaska; Callie Wentling
Journal:  J Pharmacol Exp Ther       Date:  2012-01-23       Impact factor: 4.030

5.  Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.

Authors:  Abby L Olsen; Bridget K Sackey; Cezary Marcinkiewicz; David Boettiger; Rebecca G Wells
Journal:  Gastroenterology       Date:  2011-12-24       Impact factor: 22.682

6.  Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells.

Authors:  R Jaster; G Sparmann; J Emmrich; S Liebe
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

7.  Kangxian ruangan keli inhibits hepatic stellate cell proliferation mediated by PDGF.

Authors:  Ling Yang; Chi-Zhi Zhang; Qing-Jing Zhu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

8.  Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma.

Authors:  H Reynaert; K Rombouts; A Vandermonde; D Urbain; U Kumar; P Bioulac-Sage; M Pinzani; J Rosenbaum; A Geerts
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 9.  Oxidative and nitrosative stress and fibrogenic response.

Authors:  R Urtasun; L Conde de la Rosa; N Nieto
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

Review 10.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.